About Ewopharma

Ewopharma is the successor company to M.R. Leclerc & Co., founded in 1959. From the start, our focus has been on building bridges to the pharmaceutical markets of Central Eastern Europe. Much has changed in the region since 1959 – both economically and politically – and over this period we have gained an in-depth understanding of the markets and an esteemed standing there.
While we started purely as a marketing partner for pharmaceutical companies, we have since acquired and launched proprietary products. Our brand Revalid® - a product line for holistic hair and skin care - was developed in 1992 in Switzerland. In 2011, we acquired the Irish healthcare company Newport Pharmaceuticals Ltd. giving us full ownership for dedicated countries worldwide of the antiviral drug Isoprinosine®. To strategically strengthen our position, Ewopharma acquired Neomed s.r.o. as part of a succession solution in 2023, followed by the purchase of AllergyCare Ltd. in 2024. Overseen by our head office in Schaffhausen, Switzerland, we channel our industry knowledge and experience into the successful placement of both Ewopharma and partner brands in our target markets.